I would be more comfortable with point 4 if we once again banned prescription drug advertisements.
That question wasn't directed at me, but finding out some data wouldn't be too difficult - you'd look up what life saving medicines had come to market since the stricter FDA regulations were enacted, what year the medicine entered trials, how many people died while they were in FDA trials before release. You could come up with some rough numbers for that, but the FDA doesn't post any information on added costs and deaths during trial periods. Obviously the safety trials save some lives, but the efficacy standard the FDA has is extremely high and adds millions and years to costs.
> I would be more comfortable with point 4 if we once again banned prescription drug advertisements.
The tough question is for drugs that people not be aware there's solutions for - erectile dysfunction, for instance. A lot of men just assumed that was something you had to live with when you got older before Viagra came out. Advertising for Viagra was probably a win for everyone involved - it educated doctors and patients that it's available, and obviously men and their partners were quite happy with its effects.
So some advertising definitely has positive benefits, but I see what you're getting at with snake oil claims if the FDA isn't as strict about playing gatekeeper. Something to think more about.
The key difference is in the "experimental" part, as that drug cannot be marketed until its fully approved.
The doctor would have to get permission from the patient, and their hospitals "Ethics Review Board"
http://reason.com/archives/2007/07/25/dying-for-lifesaving-d...
I have lived overseas long enough that I have been treated by licensed medical doctors in another country, who prescribed to me drugs that are not permitted in the United States. That was not a happy experience. I eventually had to have FDA-approved drugs that ACTUALLY WERE SAFE AND EFFICACIOUS sent over to me as I continued my stay in that country. There are prescribing and dispensing biases in other countries that frequently cause the most safe and effective medicines to not even be available in those countries at any price, even long after FDA approval of the best medicines in the United States.